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Background: Computerized clinical decision support (CDS) can help hospitals to improve healthcare. However, CDS
can be problematic. The purpose of this study was to discover how the views of clinical stakeholders, CDS content
vendors, and EHR vendors are alike or different with respect to challenges in the development, management, and
use of CDS.
Methods: We conducted ethnographic fieldwork using a Rapid Assessment Process within ten clinical and five
health information technology (HIT) vendor organizations. Using an inductive analytical approach, we generated
themes from the clinical, content vendor, and electronic health record vendor perspectives and compared them.
Results: The groups share views on the importance of appropriate manpower, careful knowledge management,
CDS that fits user workflow, the need for communication among the groups, and for mutual strategizing about
the future of CDS. However, views of usability, training, metrics, interoperability, product use, and legal issues
differed. Recommendations for improvement include increased collaboration to address legal, manpower,
and CDS sharing issues.
Conclusions: The three groups share thinking about many aspects of CDS, but views differ in a number of important
respects as well. Until these three groups can reach a mutual understanding of the views of the other stakeholders,
and work together, CDS will not reach its potential.
Keywords: Clinical decision support, Knowledge management, Governance, Rapid assessment processBackground
Because of current U.S. government incentives through
the American Reinvestment and Recovery Act (ARRA)
[1], hospitals and ambulatory care organizations are in-
creasingly purchasing commercial electronic health record
(EHR) systems with computerized clinical decision sup-
port (CDS), or they are buying CDS directly from content
development vendors. CDS includes “passive and active
referential information as well as reminders, alerts, and
guidelines [2], p. 524.” Although CDS has been shown to
improve healthcare processes and outcomes in a number
of studies [3-5], its potential has yet to be reached [6-11].* Correspondence: ash@ohsu.edu
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unless otherwise stated.Challenges to CDS development, management, and use
are multi-faceted and complex. They are sociotechnical in
nature, involving people, processes, and technology [12].
Key stakeholder groups include healthcare providers and
organizations, EHR system vendors, and commercial firms
offering CDS content. Prior studies concerning the socio-
technical aspects of CDS have focused on the perspectives
of individual healthcare organizations [13-16] or vendors
[17] in isolation, with no studies comparing the differing
perspectives of each stakeholder group.
Addressing the challenges of CDS development, man-
agement, and use requires a system-level view of how
multiple perspectives shape the sociotechnical landscape
of CDS [17]. To capture a picture of the entire CDS land-
scape, defined as all activities related to CDS, includingis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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care organizations, we pose the following research ques-
tion: How are the views of clinical stakeholders, CDS
content vendors, and EHR vendors alike or different with
respect to challenges in the development, management,
and use of CDS?
Methods
Because little is known about this topic, an exploratory
qualitative research design was selected for answering the
research question. Qualitative methods are most appropri-
ate in this case because research has not yet been con-
ducted to identify these challenges posed by CDS. Until
the challenges are identified, we cannot know if they are
measurable, so measurement at this point is not possible.
For example, if more were known about CDS challenges
and if they were measurable, a survey of the different
stakeholder groups to gain their perspectives might be
feasible. However, a valid survey instrument can only be
developed if a body of knowledge exists from which ques-
tions can be crafted.
We used the Rapid Assessment Process (RAP) as previ-
ously described [18] for studying 15 organizations, though
we adapted it significantly when studying vendor sites [17].
While ethnography is a mix of methods (usually observa-
tion and interviews, but it can include mapping, surveys,
and other techniques as well), RAP is a particular type of
ethnography which exploits the strengths of using multi-
disciplinary teams, a combination of quantitative and quali-
tative data-gathering instruments, engagement of those
inside the organization, and strategies for securing high
quality data in short periods of time [19]. “Critical elements
of the RAP method include: 1) developing a fieldwork
guide; 2) carefully selecting observation sites and partici-
pants; 3) thoroughly preparing for site visits; 4) partnering
with local collaborators; 5) collecting robust data by using
multiple researchers and methods; 6) analyzing and report-
ing data in a collaborative and structured way” [18], p. 299.
Qualitative research guidelines
This study adheres to the RATS guidelines [20] for qualita-
tive research review, which include principles for relevance
of the research question, appropriateness of the qualitative
methods selected, transparency of the procedures, and
soundness of the interpretive approach.
Human subjects and the consent process
Institutional review boards (IRBs) at the investigators’ insti-
tutions and each clinical site with an IRB approved the
study. Specifically, the IRBs representing Oregon Health &
Science University, the University of Texas Houston, Kaiser
Permanente Northwest, Brigham and Women’s Hospital,
HealthEast Care System, LDS Hospital, Providence Port-
land Medical Center, El Camino Hospital, The RegenstriefInstitute (for Wishard), Roudebush VA, and the RWJ Med-
ical Group approved the studies. Caritas and the Mid-
Valley IPA ceded authority to Oregon Health & Science
University. No patients were included as subjects, so pa-
tient consent was not requested. All selected subjects were
consented according to requirements of the IRB represent-
ing each site. If the site ceded authority to the principal in-
vestigator’s site (either OHSU or Brigham and Women’s
Hospital), subjects were consented using their approved
procedures. If the site required IRB approval in addition,
their procedures were also followed. The parent organiza-
tions required verbal consent (recorded for interviewees)
after the subject was handed a fact sheet about the project
and given an opportunity to ask questions about the study.
Visited sites sometimes also required written consent using
their specified forms, in which case we did both verbal and
written consents.Step 1 Development of the fieldwork guide
We developed a fieldwork guide, a compilation of tools
which includes a site profile form to be completed before
a site visit, a schedule of activities to be accomplished
before, during and after each site visit, interview guides,
forms for use during observational periods with cues for
foci, short field survey forms to be completed by 20 to 30
subjects on site through brief interviews to gain a sense of
general user perceptions, and agendas for team meetings
during site visits. This guide was revised for each site
based on what we learned at prior sites, a process reflect-
ing the iterative nature of qualitative studies. Although
RAP studies are generally conducted in the field, two of
our vendor visits were virtual because subjects were geo-
graphically distributed.Step 2 Selection of observation sites and participants
For clinical sites, five inpatient and five outpatient sites were
selected based on variation in commercial system used, ma-
turity of CDS use, geography, and governance structure [21].
For commercial sites, we purposively [18,22] selected
three different types of content vendors so that we could
gain a more comprehensive understanding of the issues.
Since every hospital we have studied purchases order sets,
medication knowledge bases, and clinical information ref-
erence resources, we approached three companies that
provided those products [17].
To select EHR vendor sites, we asked a group of experts
from healthcare and industry who regularly offer advice
about our investigations [21] to help select one primarily
ambulatory EHR firm and one primarily inpatient EHR
vendor with strong CDS products from among those used
at one or more of our clinical study sites. This would allow
us to directly compare what users and vendors said about
the same CDS products.
Table 1 Question topics for CDS study
1. Clinical site question areas 2. Vendor question areas
Background and role of interviewee Background and role of interviewee
The meaning of CDS The meaning of CDS
Culture and history of organization Your CDS product or content
Knowledge management practices About your customers and their
use of the product
Governance of CDS About the marketplace
CDS roles in your organization CDS roles in your organization
Challenges Challenges
Ash et al. BMC Medical Informatics and Decision Making  (2015) 15:35 Page 3 of 12All study participants were purposively selected. At clin-
ical sites, we selected subjects for interviewing and observ-
ing based on their CDS-related roles. We made an effort to
seek out clinical champions, normal users, and skeptical
users in addition to CDS experts who work to refine, de-
velop, and manage CDS as paid professionals [18]. During
content vendor visits, we interviewed individuals in par-
ticular roles, including the CEO, vice presidents, content
development and management staff, technical/interoper-
ability staff, and informaticians. For the EHR vendors, we
targeted staff members who were most involved with CDS.
Steps 3 and 4 Thoroughly preparing and partnering with
local collaborators
In addition to logistical preparation, preparation by the
team for each visit included learning about the site’s clinical
systems or, in the case of the vendors, the products offered.
This was done with the help of an internal collaborator
who could assist with any internal human subjects proce-
dures and identify and invite potential subjects. This per-
son also helped arrange for a virtual demonstration of the
system or product prior to the site visit.
Step 5 Collecting robust data by using multiple
researchers and methods
Data were collected by a interdisciplinary team of re-
searchers that always included clinicians, social scientists/
ethnographers/methods specialists, and informaticians.
For each on-site visit, 6–8 researchers, including senior
researchers on the team, travelled to a site. Some team
members had already worked together for 6 years before
starting this study, and others were added over time. They
included physicians, nurses, a pharmacist, a laboratory
specialist, medical anthropologists, and informaticians
with varied backgrounds. Triangulation, or gathering data
through multiple lenses from different kinds of subjects,
in multiple ways, is a hallmark of qualitative studies. We
therefore used a mix of researchers, subjects, sites, and
methods for this study.
RAP interviews are semi-structured so there is a definite
focus but the interviewee is allowed freedom to elaborate
on topics and the interviewer can pursue interesting ave-
nues. They are most often conducted by two interviewers
so that one can focus on the interviewee while the other
can write fieldnotes, manage the technology, and ask
follow-up questions from a different perspective than that
of the primary interviewer. All interviews were recorded
and transcribed. Observations were conducted in many
departments of hospitals, including laboratories and phar-
macies, as well as inpatient and outpatient clinical units
and exam rooms. Researchers practiced reflexivity [23] by
noting personal thoughts in fieldnotes and guarding
against leading questions in interviews. Broad areas ex-
plored during interviews and observations are listed inTable 1, but a tailored interview guide for each subject was
developed prior to each site visit so that questions were
relevant for the role of the interviewee. We did not conduct
formal observations within vendor organizations to avoid
intrusiveness. We visited the three content vendor sites to
conduct interviews in person. Interviews of EHR vendor
staff members were done by phone because most personnel
working with CDS are distributed across the country. We
gained further input once we had summarized results by
performing member checking [23], whereby we asked rep-
resentatives of the visited organizations to comment upon
our findings.
Data were gathered over a period of five years in three
phases. During the first phase, we were funded to study
CDS in community hospitals using RAP. Because during
that study we found that CDS in ambulatory settings was
important yet rarely studied, we sought and received fund-
ing to extend our RAP techniques for that purpose. While
both of those studies were in progress, we realized that the
picture was incomplete without the vendor view. There-
fore, we received permission from our funding agencies to
use no-cost extensions for site visits and phone interviews
with vendor representatives. Over the five-year period,
there were a number of changes in the sociotechnical en-
vironment of CDS that motivated our continuing interest
and our funders’ willingness to support the work. When
the first grant proposal was written, few community hospi-
tals and clinics had adopted CPOE with CDS, but later, be-
cause of national incentives [1], many more were moving
in that direction. Also over the years, the commercial sec-
tor increased development and sales of CDS, which en-
couraged our study of the vendor organizations. The
study therefore progressed iteratively as we gained further
knowledge and added perspectives.Step 6 Analyzing and reporting data in a collaborative
and structured way
An inductive thematic content analysis approach was used
for analyzing data [18,22,23]. We followed several of the
basic tenets of grounded theory in that when were just
Ash et al. BMC Medical Informatics and Decision Making  (2015) 15:35 Page 4 of 12beginning to explore CDS, we remained very open in our
data gathering and analysis. This meant that we conducted
line-by-line coding of interview and fieldnote text docu-
ments and identified patterns and themes directly from
the words of subjects. As we progressed in our analysis
over time, we either coded new text into categories we
had already established or created new codes, ultimately
leading to new or enhanced patterns and themes. All col-
lected data were reviewed during this process. We used
qualitative data analysis software (QSR NVivo) with initial
coding conducted by pairs of researchers. Each pair con-
sisted of one clinical and one non-clinical researcher. The
process included coding one transcript and comparing
coding, then discussing and reaching agreement on defini-
tions and meanings of codes before moving on to additional
documents. Each pair then presented the final result of its
coding to the multidisciplinary team of informatics, ethno-
graphic, and clinical experts. This coding process, as de-
scribed in a prior paper [18] led to development of the
patterns and themes described below. The interpretive
process included discussion and eventual agreement about
the naming and meaning of themes and subthemes that
arose from the data. Using a constant comparative approach,
we then analyzed differences across the themes in the clin-
ical, content vendor, and EHR vendor groups to discover the
perspective of each group related to each theme.
Results
Introduction
We conducted 15 site visits: five to inpatient settings, five
to outpatient settings, and five to vendor organizations.
We conducted 206 formal interviews with 191 subjects
(some were interviewed more than once) and performed
268 hours of observation. We approached approximately
twenty subjects who could not consent to an interview be-
cause of scheduling conflicts. Table 2 shows the timing of
the site visits, type of setting, kind of EHR system, num-
bers of interviews, number of clinics (for outpatient sites),
and hours of observation.
Table 3 shows the roles of subjects. We have attempted
to categorize them, but since roles are overlapping, titles
are varied, and backgrounds are extremely diverse [24],
the assignment to categories can only be based on our
best judgment. We define the categories as follows. MD
informatics personnel work primarily in informatics, in-
cluding in content development, though some also prac-
tice medicine part time. Other clinical informatics staff
members are also primarily informaticians but are nurses,
pharmacists, and others with clinical backgrounds. Infor-
mation technology and non-clinical informatics employees
include IT staff and informaticians without clinical de-
grees. Clinicians with some informatics responsibilities are
physicians, nurses, pharmacists, or others who spend time
in informatics roles either formal or informal, includingchairing or serving on CDS committees. Health informa-
tion management (HIM) and administrative roles are
those held by certified HIM professionals, quality improve-
ment leadership, and administrators not at the vice presi-
dential level. CEO/VP/CMO denotes chief executive officer,
vice-president, or chief medical officer, all higher-level lead-
ership positions, including those in the commercial organi-
zations. Finally, the content development and business
development/marketing designations are restricted here to
the staff in vendor organizations.
Figure 1 outlines the major themes that were shared
by the three groups. We have described themes from
the clinical perspective [21] and the content vendor per-
spective [17] in prior publications. Here, we will limit
our descriptions to themes shared by two or more of the
stakeholder groups.
In the following description of results, the quotes, which
illustrate patterns, are representative of what we heard from
numerous sources. Brackets are placed around our explana-
tions to improve readability or where we removed propri-
etary terms.
Themes shared by all three groups
Please see box A in Figure 1.
Theme 1: People
All three groups told us about new kinds of essential
people needed for CDS [24]. These include knowledge
engineers, analysts who modify content at clinical
sites, clinicians specializing in evidence-based medicine at
content vendor sites, and usability and interoperability
experts at content vendor sites. The clinical organiza-
tions need analysts with both technical skills and
knowledge of healthcare to customize CDS. Content
vendors need clinicians with skills in evidence-based
medicine and writing; EHR vendors need physician
consultants who help train staff within purchasing or-
ganizations to manage CDS and use it. The notion of
embedded employees and the need for vendor staff
members to understand healthcare issues are two spe-
cial points of interest at the intersection of the three
“workforces”.
Embedded employees
Many healthcare sites have at least one employee on site
paid by the EHR vendor or who formerly worked for the
vendor. One hospital site has numerous employees who
formerly worked for the EHR vendor and now work for the
hospital, while others (one a hospital and one a group of
clinics) have outsourced nearly all IT and informatics re-
sponsibilities to their vendors. The allegiances of embed-
ded employees are sometimes more towards either the
clinical site or to the vendor; these staff members often feel
conflicted.
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Type of System Commercial Commercial Locally developed and
commercial
Locally developed Nationally developed Commercial Commercial NA NA
Date of Visit 12/2007 2/2008 6/2008 9/2008 9/2008 12/2008 2/2009 7/2009 9/2009
Hours observing 36 26 37 20 25 33 26 NA NA
Individuals
observed
10 12 17 16 17 27 17 NA NA
Number of clinics
observed
NA NA 9 6 5 9 6 NA NA
Number of
interviews
15 12 13 9 9 9 12 6 10
First Data Bank LDS Hospital UpToDate Caritas Christi Health Care HealthEast Care System NextGen Total
Location South San Francisco CA Salt Lake City UT Waltham, MA Boston, MA Minneapolis/St. Paul MN Horsham, PA
Characteristics of setting Content vendor Community Hospital Content Vendor Community Hospital Community Hospital EHR Vendor
Type of System NA Locally developed NA Commercial Commercial NA
Date of Visit 10/2009 1/2010 3/2010 3/2010 7/2010 5/2011
Hours observing NA 19 NA 17 29 NA 268
Individuals observed NA 15 NA 12 12 NA 155
Number of clinics observed NA NA NA NA NA NA 35
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Clinical customers frequently criticized EHR vendor
employees for not having a comprehensive enough
understanding of healthcare to be able to develop or
productively customize an EHR or reports. CDS ana-
lysts at clinical sites are therefore especially delighted
when they can deal with vendor staff members who
have clinical backgrounds. Physician consultants work-
ing for EHR vendors are highly valued by physician
customers. Those representing healthcare organiza-
tions felt strongly that vendors should hire more staff
members with clinical backgrounds.
Theme 2: Knowledge management
For the clinical sites, knowledge management includes
not only selecting and modifying CDS purchased from
vendors, but also developing CDS, inventorying, updat-
ing, and continuously monitoring usefulness of CDS. For
CDS content vendors, knowledge management is essen-
tial for their ability to produce and maintain content.
Content vendors all have proprietary mechanisms for
keeping track of CDS within their organizations. They
also provide software that clinical sites can purchase to
help them to manage CDS. There are three aspects of
knowledge management (listed below) that illustrate ten-
sions among clinical sites, content vendors, and EHR
vendors.
Customization of CDS
Clinical site staff members are often frustrated that they
have to put so much effort into even the most basic CDS.
Modifying CDS so that it suits the local work process is
time-consuming. A content vendor representative noted:
“I don’t care if it’s a community [hospital] or large [hos-
pital], they don’t have the resources or the bandwidth to
do this [CDS]”.
Content vendor products
Most hospital representatives purchase some content dir-
ectly from content vendors and are often frustrated with
the products. They are concerned that content contains
too many options, is not current enough, or is not good
enough (i.e., evidence-based).
Sharing content
Representatives of all groups thought that sharing of CDS
would be an ideal but hard to reach goal. Clinical sites rarely
share CDS content they have developed. A hospital CDS
analyst said: “Some things are hard to share. So you just get
like a bunch of screen prints. . . somebody has to actually
go and program that or configure that, and it may be a six-
month effort.” Some vendors enable sharing by providing
web sites and discussion mechanisms for this purpose. Even
so, some clinical sites do not freely share because theywould like compensation or they believe sharing could
cause liability problems. Another hospital analyst noted that
an EHR vendor may be averse to the idea of customers
sharing content they paid for but the vendor developed for
them: “[CDS rules] created by the vendor consultant are
the client’s property but should not be shared because the
vendor wants to continue to make money off it [i.e., by sell-
ing the content to other healthcare customers]”.
Theme 3: Workflow
All three groups are cognizant of the impact of CDS on
the workflow of end-users, although their views differ
slightly. The clinical organizations are especially sensitive
about providing CDS that will frustrate physicians by
slowing their work with an inordinate number of alerts or
reminders. The vendors are all striving to improve work-
flow by providing more active decision support that is em-
bedded within the EHR so that the clinician does not have
to ask for it separately.
Theme 4: Communication and feedback
In this section, we focus on communication and feedback
among the three groups.
Collaboration
Collaborative communication between clinical site employees
and vendor employees ranges from daily to infrequently.
Some have good, close working relationships, while others
experience friction. Clinical staff members who manage to
find individual vendor staff members to call on a consist-
ent basis believe that is key.
Open dialogue
All three content vendors point to the need for open dia-
logue between content vendors, EHR vendors and end
users. However, dialogue is time-consuming and difficult,
and because the EHR vendors are often customers of con-
tent vendors, it can be especially complicated for them to
speak freely. An EHR vendor representative praised the
work of the HL7 standards body for promoting open dia-
logue in a legally safe environment: “in HL7 meetings you
would have the best developers from each company come
together and they would share ideas in a non-competitive
environment”.
Misunderstandings
All three groups believe the other groups do not under-
stand what they do. Clinical sites do not understand con-
tent vendors because they do not know how much effort
goes into developing CDS content; content vendors do
not understand the burden on the clinical sites to modify
the content; EHR vendors do not understand how difficult
it is for content vendors to integrate their products into
EHRs that follow different interoperability standards.
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Figure 1 Themes shared by three groups.
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Content vendors discussed the business necessity of stay-
ing (and appearing) neutral toward both EHR vendors and
end-users, given that EHR vendors are also (competing)
customers. They cannot afford to alienate potential or ac-
tual customers.
User feedback
Some vendors of both types have difficulty gaining use-
ful feedback from end-users or simply do not try. Several
strive to gather informal feedback from customers. One
actively solicits feedback through formal customer satisfac-
tion surveys and random spot-checking during implemen-
tation. Interviewees representing this vendor also talked
about involving stakeholders in developing requirements
for designing and developing CDS. They also monitor cus-
tomer use of the product to make decisions regarding fu-
ture content.
Theme 5: The future, vision, and strategy
All three groups share optimism about the future.
Corporate strategy
The companies want to continue to grow and change to
keep a competitive edge. They are working to identify new
markets and strategies and to pursue them aggressively.
They are offering varied packages to meet diverse cus-
tomer needs. These include different kinds of licensing,
training, and hosting services. They aim to be prepared
for and able to take advantage of changes in federal policy.
Interviewees from both EHR companies expressed the
idea that having a robust data analytics capacity was a
main selling point for their respective companies.Perceptions of the other
Content vendor representatives felt that because of Mean-
ingful Use there is an emerging understanding of “what
[they] do” on behalf of both the public and customers,
and that this would lead to greater customer appreciation.
The vendor representatives’ view of customers is mainly
positive in that they admire the hospitals and clinics for
being at the forefront of EHR implementation. However,
there are some undercurrents of disappointment as well.
One vendor representative expressed frustration that
the customers were motivated more to increase their
revenue than to improve patient care: “So while we have
decision support . . . the bulk of it supports making sure
they get paid.” Vendors told us customers are not clam-
oring to purchase CDS that focuses only on improving
the quality or safety of care. Customers, they believe,
often expect the software to do more than it can, but
use of these products is often suboptimal. A content
vendor employee said: “And I’ve seen several times
where the client is trying to make the products work
differently… to meet their ideal workflow in their mind
and they’re fighting the product”.
Themes shared by clinical and content vendor
groups
Please see box B in Figure 1.
Theme 6: Interoperability
Both clinical site and content vendor groups are frustrated
that more progress has not been made by EHR vendors
regarding interoperability and use of standard protocols.
With respect to CDS, the content vendors would like it to
be easier for their products to be embedded within differ-
ent commercial EHRs: “It can be sometimes a little
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There is a history of content vendors being bought by
EMR vendors and later becoming separate again [25-28],
so in these cases there remains some interoperability. One
content vendor representative recommended: “The opti-
mal way for clinical content and EHR vendors to work to-
gether is to keep separate, but standardize the interfaces
between them”.Interoperability and the relationship of clinical sites with
content vendors
Customers resent the large amount of work and re-
sources necessary to fit specific content into an EHR.
Because of this demand on resources, EHR vendors
tend to have relationships with specific content ven-
dors. Although it may be theoretically feasible for a
customer to use a different content vendor than one
that is partnered with their EHR vendor, it is often
both more difficult and costly.Interoperability and the relationship of EHR vendors and
content vendors
Interoperability between EHR and content vendor products
was described by interviewees as necessary but challenging.
A content vendor representative noted the need for collab-
orating: “But at times you really do need to come together
to say, you know, we are doing this together for a site”.Themes shared by EHR and content vendor
groups
Please see box C in Figure 1. These subthemes include
market considerations and also regulations and liability
concerns.Theme 7: Markets, products and customers
Because a number of our interviewees at vendor sites were
in marketing, we were able to discover their views on mar-
ket segmentation, what products appeal to certain markets,
and how they view their customers. Subthemes include:
who is the customer, integration, and competition.Who is the customer
All vendors talked about how they define “the customer,”
the varied and complex relationships they have with these
customers, and the differences in expectations and ap-
proach required by each. Customers include EHR vendors
that are customers of a content vendor. Health systems,
hospital IT departments, and end-user clinicians may all
be customers of either content vendors or EHR vendors..
To make matters even more complicated, agreements and
types of relationships often vary even within a single cus-
tomer category.Integration
The product that content vendors produce must be able
to be integrated into multiple EHRs in order to be com-
mercially successful. Integrating content has implications
for product design and underscores the need for effective
relationships with EHR vendors.
Competition
The overall vendor environment is increasingly competitive
and deliberately non-integrated. In order to remain com-
petitive as a business, the vendor must clearly brand prod-
ucts and keep pace with changing market expectations.
The primary niche identified by content vendors is provid-
ing evidence-based content. Content vendors also felt that
most people did not fully understand what they do, and
how resource-intensive the work is.
Liability for content
The EHR vendors and the content vendors clearly state
that they do not practice medicine and therefore should
not be liable for decisions that can only be made by clini-
cians. They provide a vehicle for using CDS content, but it
is the responsibility of the clinician to decide the medical
relevance of that content for the patient’s care.
Themes shared by EHR vendor and clinical
stakeholder groups
Please see box D in Figure 1.
Theme 8: Usability
We heard constant and strongly worded complaints from
the clinical site representatives about the usability of all
vendor-developed EHRs. We observed continuous usabil-
ity problems, defined as difficulties experienced by the
user directly interacting with the clinical information sys-
tem, which can impact the effectiveness of CDS. The EHR
vendor representatives noted that their organizations were
paying a great deal more attention to usability than ever
before. One of them said: “Well, you know, I mean cer-
tainly in the past four or five years the user interface, user
experience type people have become more in demand by
vendors and that’s probably going to continue to grow as
we hear more noise about usability”.
Theme 9: Training
Interviewees described 1) how training happens, 2) training
options (mostly provided by vendors), 3) training for differ-
ent types of clients (e.g. virtual training for small clients),
4) the role and purpose of training, and 5) the people who
do the training. At the clinical sites, vendors often do train-
ing. In the case of large clinical organizations, the EHR
vendors train trainers within the organization. They may
also train analysts and IT staff within those organizations.
In smaller organizations, the vendors may train users
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about the quality of training they received from vendors.
Conversely, the vendor representatives complained that
often, clinical organizations were too reluctant to pay for
training.
Theme 10: The meaning of CDS
Within the clinical sites, we found that the term CDS
meant different things to different study subjects [29].
Many clinical users were not familiar with the term at all.
Those who did know the term described it in either very
narrow terms (e.g. alerts and reminders) or broad terms
such as guidance provided by the EHR for making clinical
decisions. Because our study subjects within the vendor or-
ganizations were selected due to their knowledge of CDS,
they offered careful and detailed descriptions of what CDS
means to them. They universally believe a broad definition
that includes population-based reports and analytics in the
definition.
Theme 11: Measurement and metrics
Measurement of the use and effectiveness of CDS is a chal-
lenge. Representatives at one clinical site discussed how
they had difficulty accessing data for reporting because the
data were maintained in a proprietary format by their
vendor. Other representatives perceived that the difficulty
in their ability to generate reports was related to their ven-
dor’s preference to be paid to generate reports for them.
One vendor has offered free analytics capabilities for a
number of years, yet few customer organizations have
used them. However, interest among customers is increas-
ing rapidly. An EHR vendor representative said: “many
practices are interested in quality measures because of re-
imbursement, but many are also interested in improving
their care”.
Discussion
The three major stakeholder groups involved in CDS
share views on the importance of appropriate manpower,
careful knowledge management, CDS that fits user work-
flow, the need for communication among the groups, and
for mutual strategizing about the future of CDS. However,
views of usability, training, metrics, interoperability, prod-
uct use, and legal issues differed.
Strengths and weaknesses of this study
The major strengths of this study include the breadth and
variety of 1) organizations selected as sites, and 2) subjects
selected for observation and/or interviewing. This study is
unique in involving commercial as well as health care en-
tities as sites. The breadth of backgrounds represented on
the research team and the team’s experience using RAP
also strengthened the study. Other strengths, including
the ability to include senior investigators in all six RAPsteps for all site visits over five years, and to conduct espe-
cially rigorous research, were made possible by U.S. gov-
ernment funding.
Limitations include the length of the study. It is pos-
sible that, because the 15 visits spanned a period of five
years, some of the earlier subjects may now have different
opinions than what was shared in their interviews, par-
ticularly since ARRA incentives began during that period.
On the other hand, we carefully considered the temporal
factors during analysis, and this enhanced our under-
standing of the fundamental, enduring, broad themes
that were generated. Another limitation of this study was
only being able to conduct telephone interviews at some
vendor sites. In person interviews are always preferred,
but subjects belonging to these organizations were not co-
located. Although we included three major stakeholder
groups in our landscape, we were unable to gather data dir-
ectly from what may be the most influential factor, that of
the government regulators who created the legal environ-
ment surrounding these groups. Finally, because this was a
qualitative study, the results are not generalizable to all clin-
ical and vendor organizations, but they should be transfer-
able to entities similar to those studied.
Implications of results
There are many tensions among the three groups that make
up the landscape of CDS. Some tensions relate to misunder-
standings among the groups. However, subjects told us that
the most severe tensions stem from the external characteris-
tics, such as the need for national standards for interoper-
ability that are actually used by vendors. Standards would
provide a safe, legal environment in which vendors would
be empowered to provide more CDS tools to customers.
There is progress being made by standards groups and our
results underscore the importance of this work.
Interviewees want more collaboration and open dialogue.
The CDS content vendors we studied believe that they are
neutral developers of clinical content which EHR vendors
and clinicians consume. They would like to have more inter-
action with the other players in the CDS landscape. To pro-
mote adequate understanding among the most important
entities critical to successful use of CDS, a “three-way con-
versation” among content vendors, electronic health record
vendors, and users was recommended by a number of inter-
viewees. These conversations would help to achieve the mu-
tual goal of better healthcare assisted by CDS. Standards
groups provide an appropriate venue for such conversations,
as do professional associations, especially the American
Medical Informatics Association (AMIA) and HIMSS.
Relationship to other studies
Many interviewees also outlined legal issues that impede
sharing and collaboration. Authors of prior publications
have promoted this idea [30,31] and there has been some
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ator for Health Information Technology has commissioned
a research group to identify a small sub-set of medication
interaction rules that are especially useful [32]. Such pre-
selection could help users to prioritize CDS knowing there
is general agreement about some high-impact alerts. Since
this would represent a standard of care, there could be some
legal protection at least for the use of these alerts.
Most subjects outlined advantages of increased sharing.
Currently, there is no easy way for healthcare organizations
to share the clinical content. Clinical organizations cannot
continue to develop and redevelop the same CDS interven-
tions. Many interviewees felt there should be a mechanism
that allows organizations to share content and provides legal
protections to the organizations. Prior authors have outlined
how this has been accomplished in pilot studies [33-37].
The health care organizations plan to measure CDS effect-
iveness increasingly in the future, and to improve their
monitoring and reporting. The vendor organizations are de-
veloping additional tools to help them. The publication of
the six systematic reviews by Haynes et al. [6-11] made it
clear that all parties involved in the design, development,
implementation, and use of CDS interventions need to de-
velop metrics if CDS is to be evaluated in a rigorous fashion
(e.g., RCTs, usage statistics) [38].
Future research
A follow-up study after the impact of ARRA [1] becomes
clearer could offer an assessment of how issues identified in
the present study are being addressed and what challenges
remain. It would be especially useful if the study could dis-
cover the perspectives of both public and private regulatory
and accrediting bodies concerning CDS, in addition to the
clinical and commercial stakeholder groups included here.
Conclusions
By conducting site visits to 15 organizations representing
clinical users, content vendors, and EHR vendors, we gath-
ered data on the broad landscape that impacts challenges to
CDS development, management, and use. The three groups
share thinking about many aspects of CDS, but views differ
in a number of important respects as well. Until these three
groups can reach a mutual understanding of the views of
the other stakeholders, and work together, CDS will not
reach its potential.
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